Anti-KLHL7/ CISS3/ KLHL6 monoclonal antibody

Anti-KLHL7/ CISS3/ KLHL6 antibody for FACS & in-vivo assay

Target products collectionGo to KLHL7/KLHL7 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP2178-Ab-1/ GM-Tg-hg-MP2178-Ab-2Anti-Human KLHL7 monoclonal antibodyHuman
GM-Tg-rg-MP2178-Ab-1/ GM-Tg-rg-MP2178-Ab-2Anti-Rat KLHL7 monoclonal antibodyRat
GM-Tg-mg-MP2178-Ab-1/ GM-Tg-mg-MP2178-Ab-2Anti-Mouse KLHL7 monoclonal antibodyMouse
GM-Tg-cynog-MP2178-Ab-1/ GM-Tg-cynog-MP2178-Ab-2Anti-Cynomolgus/ Rhesus macaque KLHL7 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP2178-Ab-1/ GM-Tg-felg-MP2178-Ab-2Anti-Feline KLHL7 monoclonal antibodyFeline
GM-Tg-cang-MP2178-Ab-1/ GM-Tg-cang-MP2178-Ab-2Anti-Canine KLHL7 monoclonal antibodyCanine
GM-Tg-bovg-MP2178-Ab-1/ GM-Tg-bovg-MP2178-Ab-2Anti-Bovine KLHL7 monoclonal antibodyBovine
GM-Tg-equg-MP2178-Ab-1/ GM-Tg-equg-MP2178-Ab-2Anti-Equine KLHL7 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP2178-Ab-1/ GM-Tg-hg-MP2178-Ab-2; GM-Tg-rg-MP2178-Ab-1/ GM-Tg-rg-MP2178-Ab-2;
GM-Tg-mg-MP2178-Ab-1/ GM-Tg-mg-MP2178-Ab-2; GM-Tg-cynog-MP2178-Ab-1/ GM-Tg-cynog-MP2178-Ab-2;
GM-Tg-felg-MP2178-Ab-1/ GM-Tg-felg-MP2178-Ab-2; GM-Tg-cang-MP2178-Ab-1/ GM-Tg-cang-MP2178-Ab-2;
GM-Tg-bovg-MP2178-Ab-1/ GM-Tg-bovg-MP2178-Ab-2; GM-Tg-equg-MP2178-Ab-1/ GM-Tg-equg-MP2178-Ab-2
Products NameAnti-KLHL7 monoclonal antibody
Formatmab
Target NameKLHL7
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-KLHL7 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species KLHL7/ CISS3/ KLHL6 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorvGMLP001057human KLHL7 Lentivirus particle
    ORF Viral VectorpGMLP001057human KLHL7 Lentivirus plasmid
    ORF Viral VectorpGMLPm003054mouse Klhl7 Lentivirus plasmid
    ORF Viral VectorvGMLPm003054mouse Klhl7 Lentivirus particle


    Target information

    Target IDGM-MP2178
    Target NameKLHL7
    Gene ID55975,52323,362303,705349,475255,101089000,534697,100053660
    Gene Symbol and Synonyms2700038B03Rik,CISS3,D5Ertd363e,KLHL6,KLHL7,PERCHING,SBBI26
    Uniprot AccessionQ8IXQ5,Q5XHZ6
    Uniprot Entry NameKLHL7_HUMAN,KLHL7_RAT
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000122550
    Target ClassificationN/A

    The target: KLHL7, gene name: KLHL7, also named as CISS3, KLHL6, SBBI26. This gene encodes a BTB-Kelch-related protein. The encoded protein may be involved in protein degradation. Mutations in this gene have been associated with retinitis pigmentosa 42. [provided by RefSeq, Feb 2010].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.